401. Ultrasensitive analysis of mirtazapine and its metabolites enantiomers in body fluids using ultrasound-enhanced and surfactant-assisted dispersive liquid–liquid microextraction followed by polymer-mediated stacking in capillary electrophoresis.
- Author
-
Yan, Qiao-Ting, Chen, Meng-Chin, and Hsieh, Ming-Mu
- Subjects
- *
CAPILLARY electrophoresis , *LIQUID-liquid extraction , *BODY fluids , *MIRTAZAPINE , *ENANTIOMERS , *CAPILLARY liquid chromatography , *CHIRAL drugs - Abstract
• We obtained satisfactory recoveries, good sensitivity, and non-interfering eletrophoretic analysis. • Our developed system was used to quantify mirtazapine-related drugs in human fluids. • Ultrasensitive analysis of mirtazapine-related drugs was achieved by the proposed system. • The sensitivity was improved to 2700–3900 times by USA-DLLME and PDDAC-mediated CE stacking. • This system has the merits of simplicity, rapidity, separation efficiency, and sensitivity. A simple, rapid, and sensitive technique for measuring mirtazapine and its metabolites enantiomers in human fluids, such as urine and serum, was developed by applying ultrasound-enhanced and surfactant-assisted dispersive liquid–liquid microextraction (USA-DLLME) integrated with poly(diallyldimethylammonium chloride) (PDDAC)-mediated stacking in capillary electrophoresis (CE). The parameters that affect extraction and stacking performance, such as the extraction volume, surfactant types, surfactant concentrations, salt additives, extraction time, solution pH, and background electrolytes, were comprehensively studied and optimized to achieve optimal detection performance. Under optimal extraction conditions (injection of 120 µL of C 2 H 2 Cl 4 into 1 mL of a sample solution containing 0.05 mM Brij-35 at pH 10.0) and separation conditions (0.9% PDDAC, 10 mM phosphate, pH 3.0, and 20 mM dimethyl-β-cyclodextrin), on-line CE stacking of mirtazapine-related chiral drugs was achieved by the two strategies: (i) neutral DM-β-CD sweep low concentrations of DL-NaSSA and (ii) DL-NASSA is stacked by the difference in the viscosity between the PDDAC and sample zone. An approximately 2,800–4000-fold improvement in detection sensitivity was revealed for mirtazapine, N-demethylmirtazapine, and 8-hydroxymirtazapine enantiomers. The linear ranges for the quantification of all analyte enantiomers were 1.2–150 nM, with a coefficient of determination higher than 0.99; the relative standard deviations in the migration time and peak areas for six analytes were less than 1.8% and 5.8%, respectively. The proposed system provided the limits of detection (signal-to-noise ratio of 3) of the six analytes as 0.3–0.5 nM. The recovery of the six separated analytes spiked in urine and serum samples was revealed to be 82.7%–109.5% and 91%–112.8%, respectively. This advanced technique with high sensitivity enhancement factors was successfully employed to analyze mirtazapine and its metabolites enantiomers in urine and serum samples with reliability. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF